Genetic Technologies
(NASDAQ) GENE
This security has been delisted. This page is retained for historical reference.
GENE News
3 Stocks Shaking the Market
Whoa! What Just Happened to My Stock?
3 Stocks Shaking the Market
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowGENE Financials
Key Financial Metrics (TTM)
Gross Margin
51%
Operating Margin
-2%
Net Income Margin
-2%
Return on Equity
-2%
Return on Capital
-6%
Return on Assets
-2%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$3.90M
Operating Income
$12.21M
EBITDA
$11.43M
Operating Cash Flow
$9.68M
Capital Expenditure
$32.97K
Free Cash Flow
$9.71M
Cash & ST Invst.
$1.02M
Total Debt
$875.19K
Genetic Technologies Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$4.80M
-16.7%
Gross Profit
$2.80M
-27.9%
Gross Margin
58.25%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
55
N/A
Net Income
$5.60M
-72.3%
EBITDA
$5.30M
-47.8%
Quarterly Fundamentals
Net Cash
$145.42K
-98.7%
Accounts Receivable
$2.13M
-12.2%
Inventory
$206.47K
-48.1%
Long Term Debt
$22.92K
-94.1%
Short Term Debt
$852.26K
+222.7%
Return on Assets
-1.94%
N/A
Return on Invested Capital
-6.13%
N/A
Free Cash Flow
$5.67M
-259.1%
Operating Cash Flow
$5.67M
-277.8%